Larkspur Health Acquisition Corp. (LSPRU) Prices $75M IPO

Larkspur Health Acquisition Corp. announced the pricing of its $75 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LSPRU” Tuesday, December 21.

The new SPAC intends to focus on companies in the biotechnology sector and would benefit from access to public markets and the operational and strategic expertise of our management team and board of directors. Larkspur Health is led by Chairman and Chief Executive Officer, Daniel J. O’Connor and Director and Chief Financial Officer, David S. Briones.

Total SPAC deal count for 2021 year-to-date is now 609. This offering is expected to close on Thursday, December 23.

A.G.P./Alliance Global Partners is the sole book-running manager, and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as co-manager for the offering. McDermott Will & Emery LLP is serving as Issuer’s Counsel with Manatt, Phelps & Phillips, LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.